Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Cancers|October 23, 2021
Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in CancerMaria Antonia Garrido, Francisco Perea, Jose Ramon Vilchez, et al.
Human Immunology|August 7, 2007
High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancerJose M Cozar, Jose M Romero, Natalia Aptsiauri, et al.
Immunological Investigations|May 3, 2019
Association between Genetic Polymorphisms of Inflammatory Response Genes and Acute PancreatitisAntonio Rodriguez-Nicolas, Pilar Jiménez, F David Carmona, et al.
Immunogenetics|August 27, 2018
HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15María A Garrido, Teresa Rodriguez, Svitlana Zinchenko, et al.
Genes|December 30, 2025
Endometrial Microbial Profile in Infertile Women with Chronic Endometritis: Intensified Culturomics and 16S rDNA Gene SequencingBárbara Lara-Del-Río, Rocío Sánchez-Ruiz, Mónica Bernal-Sánchez, et al.
Actas Urologicas Espanolas|August 8, 2009
[Polymorphisms in inflammatory response genes in metastatic renal cancer]Pablo Sáenz López, Fernando Vázquez Alonso, José M Romero, et al.
Human Immunology|December 8, 2009
Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patientsPablo Sáenz-López, Rafael Carretero, Fernando Vazquez, et al.
International Journal of Cancer|October 28, 2016
The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltrationFrancisco Perea, Mónica Bernal, Abel Sánchez-Palencia, et al.
Immunogenetics|June 12, 2008
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapyRafael Carretero, José M Romero, Francisco Ruiz-Cabello, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2006
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccinationTeresa Cabrera, Ester Lara, José M Romero, et al.
Pageof 9